Posted on May 11, 2022

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as...

COL (Join to see)

621

5

1

3

3

0

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as...

Posted from thelancet.com

Posted in these groups: 098d857

098d857

Coronavirus COVID19 Research logo

Cw field hospital

Healthheart

A2eefb3b

Posted >1 y ago

Responses: 1

2

2

0

MAJ Bob Miyagishima

Posted >1 y ago

That Diagram above reminds me why I did not become a doctor. Lol

(2)

Comment

(0)

Read This Next

RallyPoint Home